If this really was the case, which personally I do
Post# of 157806
(Total Views: 620)
Posted On: 01/30/2022 11:21:29 AM
Re: enemyofpluto #116812
If this really was the case, which personally I doubt at this point, I would not even entertain anything under 20 Billion. Yes nothing should even be discussed under that number.
If we beat the SOC for TNBC we are already well over 20 billion. That’s a fact you can’t argue that because we know the value from previous buyouts.
So no clue but people are saying buyout at 5 bucks ect. You are smoking crack if you think that’s a good deal. Unless of course NP 3600 times better results were misleading then yes we won’t get anything near that.
This is all based on the one indication alone I mentioned. Once again this is all speculation and personally I don’t think a buyout is happening at this point just FYI. I figured I’ve been wrong so much if I keep saying a buyout won’t happen it will. So I’ll keep saying it won’t happen. Actually a buyout will never, ever happen. I’d bet all my shares it won’t.
Everyone is saying we aren’t in a strong position to negotiate. Sure good chance they are correct outside looking in but last I checked nobody here works for Cytodyn or knows what cards we are holding.
If we beat the SOC for TNBC we are already well over 20 billion. That’s a fact you can’t argue that because we know the value from previous buyouts.
So no clue but people are saying buyout at 5 bucks ect. You are smoking crack if you think that’s a good deal. Unless of course NP 3600 times better results were misleading then yes we won’t get anything near that.
This is all based on the one indication alone I mentioned. Once again this is all speculation and personally I don’t think a buyout is happening at this point just FYI. I figured I’ve been wrong so much if I keep saying a buyout won’t happen it will. So I’ll keep saying it won’t happen. Actually a buyout will never, ever happen. I’d bet all my shares it won’t.
Everyone is saying we aren’t in a strong position to negotiate. Sure good chance they are correct outside looking in but last I checked nobody here works for Cytodyn or knows what cards we are holding.
(6)
(1)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36